We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+28.48%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$4.35B
AUM Growth
+$309M
Cap. Flow
-$508M
Cap. Flow %
-11.68%
Top 10 Hldgs %
52.87%
Holding
159
New
12
Increased
33
Reduced
61
Closed
13

Top Buys

Rank Stock Value
1
LPX icon
Louisiana-Pacific
LPX
+$59.7M
2
LYB icon
LyondellBasell Industries
LYB
+$57.5M
3
ULTA icon
Ulta Beauty
ULTA
+$35.1M
4
WAB icon
Wabtec
WAB
+$34.5M
5
JD icon
JD.com
JD
+$21.3M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$101M
2
BKNG icon
Booking.com
BKNG
+$79.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$56.4M
4
MTN icon
Vail Resorts
MTN
+$49.6M
5
GOGL
Golden Ocean Group
GOGL
+$45.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.71%
2 Industrials 21.51%
3 Technology 19.57%
4 Materials 8.65%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LIVN icon
76
LivaNova
LIVN
$4.21B
$2.75M 0.06%
41,603
– –
HCM icon
77
HUTCHMED
HCM
$2.18B
$2.72M 0.06%
85,055
– –
IDYA icon
78
IDEAYA Biosciences
IDYA
$3.54B
$2.7M 0.06%
193,123
– –
ADI icon
79
Analog Devices
ADI
$187B
$2.68M 0.06%
18,145
+977
+6% +$130K
DNLI icon
80
Denali Therapeutics
DNLI
$4B
$2.58M 0.06%
30,791
-40,002
-57% -$2.42M
ZYME icon
81
Zymeworks
ZYME
$1.71B
$2.47M 0.06%
52,327
– –
IMTX icon
82
Immatics
IMTX
$1.33B
$2.47M 0.06%
228,960
– –
CHRS icon
83
Coherus Oncology
CHRS
$192M
$2.47M 0.06%
142,034
– –
NTLA icon
84
Intellia Therapeutics
NTLA
$1.68B
$2.45M 0.06%
44,963
-20,068
-31% -$729K
CYPH
85
Cypherpunk Technologies Inc
CYPH
$72.4M
$2.4M 0.06%
106,526
+64,479
+153% +$1.23M
BCAB icon
86
BioAtla
BCAB
$5.76M
$2.38M 0.05%
+1,400
New +$2.34M
BIO icon
87
Bio-Rad Laboratories Class A
BIO
$9.48B
$2.35M 0.05%
4,024
+1,662
+70% +$947K
RCUS icon
88
Arcus Biosciences
RCUS
$3.66B
$2.26M 0.05%
87,058
– –
ORCL icon
89
Oracle
ORCL
$435B
$2.06M 0.05%
31,874
-122
-0.4% -$7.26K
RVTY icon
90
Revvity
RVTY
$12.9B
$2.04M 0.05%
14,180
-5,873
-29% -$782K
CTMX icon
91
CytomX Therapeutics
CTMX
$750M
$1.99M 0.05%
303,465
+103,241
+52% +$738K
INBX
92
DELISTED
Inhibrx, Inc. Common Stock
INBX
$1.98M 0.05%
60,105
-14,895
-20% -$396K
BCEL
93
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$1.93M 0.04%
119,751
– –
ARCT icon
94
Arcturus Therapeutics
ARCT
$200M
$1.92M 0.04%
+44,333
New +$3M
ROKU icon
95
Roku
ROKU
$22.5B
$1.88M 0.04%
5,661
-1,737
-23% -$456K
ADPT icon
96
Adaptive Biotechnologies
ADPT
$4.05B
$1.78M 0.04%
30,028
– –
XLRN
97
DELISTED
Acceleron Pharma
XLRN
$1.77M 0.04%
13,872
– –
AAPL icon
98
Apple
AAPL
$4.5T
$1.7M 0.04%
12,788
– –
INTC icon
99
Intel
INTC
$492B
$1.69M 0.04%
33,932
-252,463
-88% -$12.3M
WVE icon
100
Wave Life Sciences
WVE
$1.2B
$1.62M 0.04%
206,384
– –
2 3
4
5 6

Similar funds

EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
HBFP
Henderson Brothers Financial Partners Pittsburgh, Pennsylvania $395M AUM

Platinum Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Platinum Investment Management held 159 positions worth $4.35B, up 7.6% from $4.04B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Platinum Investment Management withdrew a net $508M in Q4 2020, closing 13 positions and reducing 61 holdings. Its most notable exit was Golden Ocean Group, an estimated $45.8M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 31% a quarter earlier, followed by Industrials and Technology.

Against the trend, Platinum Investment Management opened a new position in Starbucks worth $7.24M.

  • Platinum Investment Management's largest Q4 2020 buy was Starbucks: 67,648 shares worth $7.24M.
  • Platinum Investment Management added most to Louisiana-Pacific in Q4 2020, an estimated $59.7M increase.
  • Platinum Investment Management's biggest Q4 2020 reduction was Alibaba, cutting an estimated $101M.
  • Platinum Investment Management fully exited Golden Ocean Group in Q4 2020, selling an estimated $45.8M.
  • Platinum Investment Management's ten largest holdings make up 53% of its $4.35B portfolio in Q4 2020.
  • Platinum Investment Management opened 12 new positions and closed 13 in Q4 2020.
  • Platinum Investment Management's portfolio value rose 7.6% quarter-over-quarter to $4.35B.

Based on Platinum Investment Management's 13F filing for Q4 2020, filed 12 Feb 2021.